BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Helsinn Healthcare SA 

P.O. Box 357

Pambio-Noranco    6915  Switzerland
Phone: 41-91-985-21-21 Fax: +41-91-993-21-22


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Healthcare






 Company News
Zealand Pharma and Helsinn Healthcare SA Announce Helsinn’s Decision to Advance the Development of Elsiglutide into Phase IIb for the Prevention of Chemotherapy-Induced Diarrhea 5/28/2013 9:09:30 AM
Zealand Pharma Receives Milestone Payment from Helsinn Healthcare SA 12/9/2010 11:24:11 AM
Helsinn Healthcare SA and Eisai Inc. (ESALF.PK) Extend Relationship 6/9/2010 9:35:36 AM
Helsinn Healthcare SA Announces the Acquisition of Sapphire Therapeutics, Inc. to Establish Helsinn Therapeutics (US) Inc. 1/28/2009 11:27:12 AM
Helsinn Healthcare SA Announces Partnering Agreement for ZP1846, a Novel GLP-2 Agonist from Zealand Pharma 12/11/2008 8:52:29 AM
Zealand Pharma and Helsinn Healthcare SA Sign a €140 Million (US$176.8 Million) Partnering Agreement for ZP1846, a Novel GLP-2 Agonist 12/1/2008 11:21:36 AM
MGI PHARMA, INC. (MOGN) and Helsinn Healthcare SA Announce sNDA for Aloxi Capsules Accepted for Review by U.S FDA 1/3/2008 10:42:39 AM
MGI PHARMA, INC. (MOGN) and Helsinn Healthcare SA Announce Submission of Supplemental New Drug Application for Aloxi(R) Capsules 10/30/2007 12:24:33 PM
MGI PHARMA, INC. (MOGN) and Helsinn Healthcare SA Announce Aloxi(R) sNDA Approval Allowing for Repeated Dosing for Cancer Patients Receiving Multiple Day Chemotherapy Regimens 9/4/2007 11:49:13 AM
MGI PHARMA, INC. (MOGN) and Helsinn Healthcare SA Announce Aloxi sNDA for PONV Accepted for Review By U.S. FDA 7/9/2007 12:00:44 PM
123